title: Does pain at tumor site during vinorelbine infusion affect treatment of recurrent head and neck cancer patients?
authors.forename: S
authors.initials: S
authors.lastname: De Marco
authors.forename: A
authors.initials: A
authors.lastname: Fabi
authors.forename: A
authors.initials: A
authors.lastname: Ceribelli
authors.forename: P
authors.initials: P
authors.lastname: Carlini
authors.forename: C F
authors.initials: CF
authors.lastname: Pollera
authors.forename: F
authors.initials: F
authors.lastname: Cognetti
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010146:Pain / Q000209:etiology*; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D000077235:Vinorelbine